Literature DB >> 20024494

Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis.

S Panzer1, R Badr Eslam, A Schneller, A Kaider, D Koren, B Eichelberger, R Rosenhek, U Budde, I M Lang.   

Abstract

Severe aortic stenosis is associated with a haemostatic abnormality that resembles acquired von Willebrand syndrome type 2. It is assumed that high shear conditions render large von Willebrand factor (VWF) multimers accessible to cleavage by ADAMTS-13. However, whether loss of these large multimers affects platelet function by impairing adhesion, aggregate formation, or both has not been evaluated in clinical studies. We prospectively enrolled 47 patients with severe aortic stenosis, and studied them prior to aortic valve surgery and at a median of six months after valve replacement. We investigated levels of large VWF multimers, platelet function under high shear conditions, and residual response to suboptimal concentrations of ADP to express P-selectin. As expected, there was a significant reduction of VWF large multimers before surgery that resolved thereafter in most patients (p<0.0001). The closure time of the ADP cartridge of the PFA-100 was also corrected in most patients after the operation (p<0.0001). We used the cone and plate(let) analyser Impact-R to differentiate between adhesion and aggregation. Both adhesion (p=0.03) and ADP-inducible platelet aggregation (p=0.002) improved considerably after valve replacement. Consequently, ADP-inducible expression of P-selectin was higher after valve replacement (p=0.001). We conclude that reduced levels of large VWF multimers associated with aortic stenosis lead to impairment of both adhesion and, especially, ADP-inducible platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20024494     DOI: 10.1160/TH09-06-0391

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

Review 1.  Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science.

Authors:  Soundarya Selvam; Paula James
Journal:  Semin Thromb Hemost       Date:  2017-05-05       Impact factor: 4.180

2.  Platelet reactivity in patients undergoing transcatheter aortic valve implantation.

Authors:  Katia Orvin; Alon Eisen; Leor Perl; Noa Zemer-Wassercug; Pablo Codner; Abid Assali; Hana Vaknin-Assa; Eli I Lev; Ran Kornowski
Journal:  J Thromb Thrombolysis       Date:  2016-07       Impact factor: 2.300

3.  Hemostatic abnormalities in adult patients with Marfan syndrome.

Authors:  Katharina T I Kornhuber; Heide Seidel; Claudia Pujol; Christian Meierhofer; Franz Röschenthaler; Axel Pressler; Alexander Stöckl; Nicole Nagdyman; Rhoia C Neidenbach; Philipp von Hundelshausen; Martin Halle; Stefan Holdenrieder; Peter Ewert; Harald Kaemmerer; Michael Hauser
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

4.  Treatment of Heyde's Syndrome by Aortic Valve Replacement.

Authors:  Ramzi Abi-Akar; Issam El-Rassi; Nicole Karam; Yehya Jassar; Rita Slim; Victor Jebara
Journal:  Curr Cardiol Rev       Date:  2011-02

Review 5.  Mechanobiology of platelets: techniques to study the role of fluid flow and platelet retraction forces at the micro- and nano-scale.

Authors:  Shirin Feghhi; Nathan J Sniadecki
Journal:  Int J Mol Sci       Date:  2011-12-07       Impact factor: 5.923

6.  Rapid Restoration of Thrombus Formation and High-Molecular-Weight von Willebrand Factor Multimers in Patients with Severe Aortic Stenosis After Valve Replacement.

Authors:  Keigo Yamashita; Hideo Yagi; Masaki Hayakawa; Takehisa Abe; Yoshihiro Hayata; Naoko Yamaguchi; Mitsuhiko Sugimoto; Yoshihiro Fujimura; Masanori Matsumoto; Shigeki Taniguchi
Journal:  J Atheroscler Thromb       Date:  2016-04-05       Impact factor: 4.928

7.  Characterization of Von Willebrand Factor Multimer Structure in Patients With Severe Aortic Stenosis.

Authors:  Joerg Kellermair; Helmut W Ott; Michael Spannagl; Josef Tomasits; Juergen Kammler; Hermann Blessberger; Christian Reiter; Clemens Steinwender
Journal:  Clin Appl Thromb Hemost       Date:  2017-12-04       Impact factor: 2.389

8.  Decreased plasma ADAMTS-13 activity as a predictor of postoperative bleeding in cyanotic congenital heart disease.

Authors:  Rosangela P S Soares; Sérgio P Bydlowski; Marcelo B Jatene; Janete Ferreira Hironaka; Antonio Augusto Lopes
Journal:  Clinics (Sao Paulo)       Date:  2013-04       Impact factor: 2.365

9.  Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease.

Authors:  R P S Soares; S P Bydlowski; N M Nascimento; A M Thomaz; E N M Bastos; A A Lopes
Journal:  Braz J Med Biol Res       Date:  2013-04-05       Impact factor: 2.590

Review 10.  Shear Stress-Induced Activation of von Willebrand Factor and Cardiovascular Pathology.

Authors:  Sergey Okhota; Ivan Melnikov; Yuliya Avtaeva; Sergey Kozlov; Zufar Gabbasov
Journal:  Int J Mol Sci       Date:  2020-10-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.